Michael Skynner
Hoofd Techniek/Wetenschap/O&O bij BICYCLE THERAPEUTICS PLC
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Michael Skynner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BICYCLE THERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 03-01-2022 | - |
Operationeel Directeur | 01-01-2018 | 03-01-2022 | |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Operationeel Directeur | 01-01-2018 | - |
Loopbaan van Michael Skynner
Eerdere bekende functies van Michael Skynner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01-09-2013 | 01-01-2016 |
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Oprichter | 01-05-2001 | 01-05-2005 |
Opleiding van Michael Skynner
Imperial College London | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Verenigde Staten | 3 |
Operationeel
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BICYCLE THERAPEUTICS PLC | Health Technology |
PFIZER, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Commercial Services |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Health Technology |
- Beurs
- Insiders
- Michael Skynner
- Ervaring